Related Experiment Video
Updated: Jan 21, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation
Insights
Familial hypocalciuric hypercalcemia in a child was linked to novel SPINK1/AP2S1 gene mutations. Cinacalcet treatment effectively prevented acute recurrent pancreatitis recurrence for six years.
Area of Science:
- Genetics
- Endocrinology
- Pediatrics
Background:
- Familial hypocalciuric hypercalcemia (FHH) is a genetic disorder causing high calcium levels with low urinary calcium excretion.
- Acute recurrent pancreatitis (ARP) in children is uncommon, with hypercalcemia and SPINK1 gene mutations being potential risk factors.
Observation:
- A pediatric case presented with a rare genetic/metabolic form of ARP.
- This patient had compound heterozygous mutations in both the SPINK1 and AP2S1 genes.
Findings:
- The study identified a novel combination of SPINK1 and AP2S1 mutations contributing to ARP.
- Treatment with cinacalcet completely prevented ARP recurrence in this child for six years.
Implications:
- This case highlights a new genetic basis for ARP in children.
- Cinacalcet demonstrates potential as a preventive therapy for ARP in specific genetic contexts.
- Understanding these genetic links can improve diagnosis and management of pediatric pancreatitis.
Abstract:
Familial hypocalciuric hypercalcemia is an autosomal dominant genetic disorder characterized by hypercalcemia associated with inappropriate hypocalciuria and normal parathyroid hormone levels. Acute recurrent pancreatitis (ARP) is rare in children. Predisposing factors include hypercalcemia and mutations in the serine protease inhibitor Kazal-type 1 (SPINK1) gene. The disease carries a heavy morbidity and preventive treatment options are scant. Here, we report a child with a novel genetic/metabolic form of ARP associated with compound heterozygous SPINK1/AP2S1 (adaptor protein-2 σ1-subunit) mutations, recurrence of which was completely abrogated for 6 years by cinacalcet treatment.
Related Concept Videos
Sustainable Development
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Design Example: Sustainability in Concrete Building
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
Cancer Prevention
Some...

